Skip to content
Phone: 301-655-1084 Email: info@glycorx.com

GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)

July 18, 2018

GlycoMantra received SBIR Phase 1 grant from the NCI (NIH)

GlycoMantra was awarded SBIR Phase 1 grant to investigate drug resistance in metastatic prostate cancer.

Glycomantra Staff

Back To Top